Community Healthcare Analyst Ratings
Community Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/08/2023 | 36.31% | Truist Securities | $44 → $36 | Maintains | Buy |
11/02/2023 | 51.46% | Piper Sandler | $50 → $40 | Maintains | Overweight |
11/02/2023 | 21.17% | Evercore ISI Group | $36 → $32 | Downgrades | Outperform → In-Line |
09/22/2023 | 24.95% | Baird | $43 → $33 | Downgrades | Outperform → Neutral |
07/06/2023 | — | Colliers Securities | Upgrades | Neutral → Buy | |
02/16/2023 | 62.82% | Baird | $38 → $43 | Maintains | Outperform |
01/17/2023 | 81.75% | Truist Securities | $43 → $48 | Maintains | Buy |
01/17/2023 | 70.39% | Piper Sandler | $41 → $45 | Maintains | Overweight |
01/13/2023 | 66.6% | Janney Montgomery Scott | → $44 | Upgrades | Neutral → Buy |
10/07/2022 | 55.24% | Piper Sandler | $45 → $41 | Maintains | Overweight |
09/27/2022 | 62.82% | Evercore ISI Group | $45 → $43 | Maintains | Outperform |
07/11/2022 | 66.6% | Truist Securities | $49 → $44 | Maintains | Buy |
11/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
08/06/2020 | 108.25% | Piper Sandler | $38 → $55 | Maintains | Overweight |
06/08/2020 | 62.82% | Evercore ISI Group | → $43 | Downgrades | Outperform → In-Line |
05/14/2020 | 43.88% | Piper Sandler | $35 → $38 | Maintains | Overweight |
05/07/2020 | 51.46% | B. Riley Securities | → $40 | Downgrades | Buy → Neutral |
04/23/2020 | 47.67% | SunTrust Robinson Humphrey | $46 → $39 | Maintains | Buy |
03/20/2020 | 51.46% | B. Riley Securities | $47 → $40 | Upgrades | Neutral → Buy |
03/06/2020 | 77.96% | B. Riley Securities | $42 → $47 | Maintains | Neutral |
02/28/2020 | 96.9% | Baird | $48 → $52 | Maintains | Outperform |
11/18/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
11/07/2019 | 59.03% | B. Riley Securities | $38 → $42 | Maintains | Neutral |
07/10/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
04/23/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
04/10/2019 | 51.46% | Baird | → $40 | Initiates Coverage On | → Outperform |
03/28/2019 | 43.88% | DA Davidson | → $38 | Initiates Coverage On | → Neutral |
11/16/2018 | -92.43% | UBS | → $2 | Initiates Coverage On | → Sell |
11/12/2018 | 17.38% | B. Riley Securities | $32 → $31 | Maintains | Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
11/08/2023 | 36.31% | Truist 证券 | 44 美元 → 36 美元 | 维护 | 买 |
11/02/2023 | 51.46% | 派珀·桑德勒 | 50 美元 → 40 美元 | 维护 | 超重 |
11/02/2023 | 21.17% | Evercore ISI 集团 | 36 美元 → 32 美元 | 降级 | 跑赢大盘 → 在线 |
09/22/2023 | 24.95% | 贝尔德 | 43 美元 → 33 美元 | 降级 | 跑赢大盘 → 中性 |
07/06/2023 | — | 高力证券 | 升级 | 中性 → 买入 | |
02/16/2023 | 62.82% | 贝尔德 | 38 美元 → 43 美元 | 维护 | 跑赢大盘 |
01/17/2023 | 81.75% | Truist 证券 | 43 美元 → 48 美元 | 维护 | 买 |
01/17/2023 | 70.39% | 派珀·桑德勒 | 41 美元 → 45 美元 | 维护 | 超重 |
01/13/2023 | 66.6% | 詹尼蒙哥马利斯科特 | → 44 美元 | 升级 | 中性 → 买入 |
2022 年 7 月 10 日 | 55.24% | 派珀·桑德勒 | 45 美元 → 41 美元 | 维护 | 超重 |
09/27/2022 | 62.82% | Evercore ISI 集团 | 45 美元 → 43 美元 | 维护 | 跑赢大盘 |
2022 年 11 月 7 日 | 66.6% | Truist 证券 | 49 美元 → 44 美元 | 维护 | 买 |
11/25/2020 | — | Evercore ISI 集团 | 升级 | 盘中 → 跑赢大盘 | |
08/06/2020 | 108.25% | 派珀·桑德勒 | 38 美元 → 55 美元 | 维护 | 超重 |
06/08/2020 | 62.82% | Evercore ISI 集团 | → 43 美元 | 降级 | 跑赢大盘 → 在线 |
05/14/2020 | 43.88% | 派珀·桑德勒 | 35 美元 → 38 美元 | 维护 | 超重 |
05/07/2020 | 51.46% | B. 莱利证券 | → 40 美元 | 降级 | 买入 → 中性 |
04/23/2020 | 47.67% | SunTrust 罗宾逊·汉弗莱 | 46 美元 → 39 美元 | 维护 | 买 |
03/20/2020 | 51.46% | B. 莱利证券 | 47 美元 → 40 美元 | 升级 | 中性 → 买入 |
03/06/2020 | 77.96% | B. 莱利证券 | 42 美元 → 47 美元 | 维护 | 中立 |
2020 年 2 月 28 日 | 96.9% | 贝尔德 | 48 美元 → 52 美元 | 维护 | 跑赢大盘 |
11/18/2019 | — | 派珀·桑德勒 | 升级 | 持有 → 买入 | |
11/07/2019 | 59.03% | B. 莱利证券 | 38 美元 → 42 美元 | 维护 | 中立 |
2019 年 10 月 7 日 | — | 詹尼蒙哥马利斯科特 | 降级 | 买入 → 中性 | |
04/23/2019 | — | 贝伦贝格 | 启动覆盖范围开启 | → 购买 | |
2019 年 10 月 4 日 | 51.46% | 贝尔德 | → 40 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
03/28/2019 | 43.88% | DA Davidson | → 38 美元 | 启动覆盖范围开启 | → 中立 |
11/16/2018 | -92.43% | 瑞银(UBS) | → 2 美元 | 启动覆盖范围开启 | → 卖出 |
11/12/2018 | 17.38% | B. 莱利证券 | 32 美元 → 31 美元 | 维护 | 中立 |
What is the target price for Community Healthcare (CHCT)?
社区医疗保健(CHCT)的目标价格是多少?
The latest price target for Community Healthcare (NYSE: CHCT) was reported by Truist Securities on November 8, 2023. The analyst firm set a price target for $36.00 expecting CHCT to rise to within 12 months (a possible 36.31% upside). 9 analyst firms have reported ratings in the last year.
Truist Securities于2023年11月8日公布了社区医疗(纽约证券交易所代码:CHCT)的最新目标股价。该分析公司将目标股价定为36.00美元,预计CHCT将在12个月内升至12个月内(可能上涨36.31%)。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Community Healthcare (CHCT)?
社区医疗保健(CHCT)的最新分析师评级是多少?
The latest analyst rating for Community Healthcare (NYSE: CHCT) was provided by Truist Securities, and Community Healthcare maintained their buy rating.
Truist Securities对社区医疗保健(纽约证券交易所代码:CHCT)的最新分析师评级由Truist Securities提供,社区医疗维持买入评级。
When is the next analyst rating going to be posted or updated for Community Healthcare (CHCT)?
社区医疗保健(CHCT)的下一次分析师评级何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Healthcare was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与社区医疗保健的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。社区医疗保健的最新评级是在2023年11月8日公布的,因此您应该预计下一个评级将在2024年11月8日左右公布。
Is the Analyst Rating Community Healthcare (CHCT) correct?
分析师对社区医疗保健(CHCT)的评级是否正确?
While ratings are subjective and will change, the latest Community Healthcare (CHCT) rating was a maintained with a price target of $44.00 to $36.00. The current price Community Healthcare (CHCT) is trading at is $26.41, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的社区医疗保健(CHCT)评级维持不变,目标股价为44.00美元至36.00美元。社区医疗保健(CHCT)目前的交易价格为26.41美元,超出了分析师的预期区间。